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ericentric heterochromatin plays an important role in
epigenetic gene regulation. We show that pericentric
heterochromatin aggregates during myogenic differ-
entiation. This clustering leads to the formation of large
chromocenters and correlates with increased levels of the
methyl CpG–binding protein MeCP2 and pericentric DNA
methylation. Ectopic expression of ﬂuorescently tagged
MeCP2 mimicked this effect, causing a dose-dependent
clustering of chromocenters in the absence of differentia-
tion. MeCP2-induced rearrangement of heterochromatin
P
 
occurred throughout interphase, did not depend on the
H3K9 histone methylation pathway, and required the
methyl  CpG–binding domain (MBD) only. Similar to
MeCP2, another methyl CpG–binding protein, MBD2,
also increased during myogenic differentiation and could
induce clustering of pericentric regions, arguing for func-
tional redundancy. This MeCP2- and MBD2-mediated
chromatin reorganization may thus represent a molecular
link between nuclear genome topology and the epigenetic
maintenance of cellular differentiation.
 
Introduction
 
Most studies trying to understand how, during development, a
multitude of different cell types with specific phenotypes and
functions can arise from a pluripotent state have focused on tran-
scriptional activation. The latter would, in a sequential manner,
commit the cell to a specific lineage. Another view considers
cellular differentiation as a progression of silencing events lead-
ing to an increasing inactivation of the genome. There is aug-
menting evidence in favor of gene silencing as cell fate determi-
nant (for review see Fisher and Merkenschlager, 2002). Studies
in yeast (Maillet et al., 1996), 
 
Drosophila
 
 (Dernburg et al.,
1996), and in mammals (Brown et al., 1997) have provided
strong evidence for a role of nuclear topology, in particular
heterochromatin proximity (in cis or in trans), in transcrip-
tional silencing (for review see Kosak and Groudine, 2004).
In mammals, heterochromatin is characterized by high
levels of specifically methylated forms of histone H3, deacety-
lated histone H4, and DNA methylation. Both methylation of
histone H3 (at lysine 9) and methylation of cytosines (at CpG
dinucleotides) are binding sites for chromatin modifiers such as
the HP1 proteins and the methyl CpG–binding domain (MBD)
proteins, respectively. The latter “translate” the DNA methyla-
tion signal into transcriptional repression at least partially by
recruiting silencing complexes and histone deacetylases, thereby
stabilizing and consolidating the heterochromatic state (for re-
view see Bird and Wolffe, 1999; Leonhardt and Cardoso, 2000).
Both HP1 (Furuta et al., 1997) and MeCP2 (Lewis et al., 1992)
(the founding member of the MBD family) have been shown to
be highly concentrated at pericentric heterochromatin. Binding
of MeCP2 to pericentric heterochromatin is dependent on DNA
methylation and requires the MBD (Nan et al., 1996). Mutations
in the MeCP2 gene were linked to Rett syndrome, a common
neurodevelopmental disorder in humans (Amir et al., 1999). The
MeCP2 protein level has been shown to increase during neu-
ronal differentiation (Jung et al., 2003) and was suggested to be
critical for synaptogenesis (Mullaney et al., 2004), maturation,
and maintenance of neurons (Kishi and Macklis, 2004).
Studies on mouse neurons (Manuelidis, 1985; Martou and
De Boni, 2000; Solovei et al., 2004) indicated a specific rearrange-
ment of centromeric domains in terminally differentiated cells. We
have set out to test whether large-scale reorganization of hetero-
chromatin within the nucleus is a feature of terminal differentia-
tion and whether histone H3K9 or DNA methylation and its trans-
lation by MBD proteins play an important role in this process.
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Abbreviations used in this paper: coRID, corepressor interacting domain; MBD,
methyl CpG–binding domain; TRD, transcriptional repressor domain.
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Results
 
MeCP2 expression and pericentric DNA 
methylation increase during myogenesis
 
To elucidate epigenetic changes taking place during cellular dif-
ferentiation, we tested whether DNA methylation and expres-
sion of its binding factor MeCP2 correlated with differentiation.
For that purpose, we made use of a well-established in vitro cul-
ture system for muscle differentiation. Pmi28 primary myo-
blasts (Kaufmann et al., 1999) or the C2C12 myoblast cell line
(Yaffe and Saxel, 1977) were induced to undergo myogenic dif-
ferentiation by incubating the cultures with horse serum con-
taining medium. After 3–4 d, the cells formed polynucleated
syncitial myotubes with a few still-mononucleated cells (myo-
cytes) that expressed muscle-specific markers (unpublished
data). Recent studies have shown that MeCP2 expression in-
creases during neuronal differentiation in humans (LaSalle et
al., 2001), rats (Jung et al., 2003), and mice (Cohen et al., 2003).
To test whether MeCP2 levels would also increase during myo-
genesis, we compared endogenous MeCP2 levels in myoblasts
versus myotubes by immunofluorescence and Western blotting.
In myoblast cultures only 11% of the cells analyzed exhibited
the typical MeCP2 pattern at pericentric heterochromatin (Fig.
1 B), whereas in myotubes almost all nuclei (99%) showed
MeCP2 staining (Fig. 1, A and C). In myocytes, 75% showed
detectable MeCP2 at pericentric sites, suggesting that the in-
crease of MeCP2 protein is gradual during differentiation and
precedes myotube formation. The dramatic increase in MeCP2
expression demonstrated in situ by immunofluorescence could
be corroborated by Western blot analysis. Equivalent amounts
of total nuclear protein from cultures of undifferentiated myo-
blasts and terminally differentiated myotubes was compared
and, as shown in Fig. 1 D, the MeCP2 level was undetectable in
proliferating myoblasts but highly enriched in myotubes.
We then investigated the level and localization of meth-
ylated CpGs (5mC) to which MeCP2 selectively binds in
myoblasts versus myotubes using specific antibodies, as well as
by Southern blot analysis using methylation sensitive restriction
enzyme digestion of genomic DNA. Intensive antibody staining
of pericentric heterochromatin was observed in an increasing
percentage of nuclei from myoblasts (23%) over myocytes
(54%) to myotubes (70%), thus paralleling the MeCP2 results
(Fig. 1 C). The lack of detectable antibody staining in a substan-
tial part of cells in all three populations is most likely due to
lower DNA methylation levels that are below the detection
threshold of the in situ immunological procedure. In fact, diges-
tion of genomic DNA with the methylation-sensitive restriction
enzyme HpyCH4 IV and subsequent Southern blot analysis
showed general methylation of the major satellite regions in
myoblasts, albeit to a reproducible lesser extent than in myo-
tubes (Fig. 1 E) corroborating these in situ results.
 
Clustering of pericentric 
heterochromatin during terminal 
differentiation
 
Because MeCP2 and DNA methylation have been implicated in
heterochromatin formation and maintenance, we tested whether
pericentric heterochromatin, which is highly enriched in both,
undergoes structural changes during differentiation. To visualize
the nuclear organization of pericentric heterochromatin during
terminal differentiation, we used 3D-FISH (Solovei et al., 2001)
with a major satellite-specific probe. Mouse pericentric hetero-
chromatin consists of large arrays of tandem major satellite re-
peats. It accounts for 
 
 
 
10% of the genome (Mitchell, 1996) and
shows a tendency to form clusters, so-called chromocenters
(Hsu et al., 1971). The mean number of chromocenters in termi-
nally differentiated cells (11.1) versus undifferentiated precur-
sors (20.4) was markedly reduced (Fig. 2), whereas the size of
the clusters increased concomitantly. The decrease in numbers
was statistically highly significant (P 
 
 
 
 0.001). Moreover, the
variability in chromocenter number within myotube nuclei di-
minished, as the SD dropped from 6.1 to 2.9 (Fig. S1, available
Figure 1. MeCP2 level increases during myo-
genesis and is paralleled by an increased
methylation of pericentric DNA. (A) Undiffer-
entiated and differentiated Pmi28 cultures
were immunolabeled for MeCP2 (green) and
counterstained with TO-PRO3 (red). Panels in
A show two equally sized areas of an undiffer-
entiated myoblast culture (top) and of a culture
3 d after induction of differentiation (bottom).
Although in the myoblast culture only two cells
show MeCP2 staining (arrowheads), in the dif-
ferentiated culture many myocytes (MC) and
almost all myotube nuclei (MT) are stained
(arrows). Bar, 20  m. 230 myoblast, 220
myocyte, and 214 myotube nuclei were
scored for detectable MeCP2 signals. B exem-
plifies the scoring on five myocyte nuclei:
three nuclei show no detectable MeCP2 sig-
nals ( ), whereas two exhibit the characteristic
MeCP2 pattern ( ) with most of the protein being localized at pericentric heterochromatin. Bar, 20  m. (C) The histogram summarizes the quantification
of detectable MeCP2 signals and of highly methylated DNA in pericentric regions of myoblast, myocytes, and myotubes. DNA methylation was assessed
using an mAb against 5-methyl-cytosine (5mC). Scoring was performed as for MeCP2. (D) A Western blot analysis comparing endogenous protein levels
of MeCP2 in C2C12 myoblasts versus myotubes. Histone level was used as control for loading of nuclear proteins. (E) Southern blot analysis of genomic
DNA from myoblasts (MB) versus myotubes (MT) digested with the methylation-sensitive restriction enzyme HpyCH4 IV (5 -ACGT-3 ). Digested DNA was
probed with a major satellite-specific probe. Note the higher concentration of undigested high molecular weight DNA in the myotube sample, indicating
an increased methylation level. 
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at http://www.jcb.org/cgi/content/full/jcb.200502062/DC1).
This substantial increase in heterochromatin clustering is proba-
bly a continuous process in myoblast-to-myotube transition, as
myocytes, which represent an intermediate differentiation state,
showed an intermediate number of chromocenters (average 14.5
SD 
 
 
 
 4.4; see Fig. 5 B and Fig. S1).
We observed such an increased clustering of pericentric
heterochromatin also during terminal differentiation of mouse
embryonic stem cells to macrophages (unpublished data).
Moreover, this phenomenon has been reported in other cell lin-
eages and species (human neutrophils [Beil et al., 2002]; hu-
man and mouse neurons [Manuelidis, 1985; Martou and De
Boni, 2000; Solovei et al., 2004]; rat myoblasts [Chaly and
Munro, 1996]) and thus may represent a general feature of ter-
minal differentiation. Given the substantial increase of MeCP2
expression accompanying this heterochromatic reorganization
during myogenic differentiation and considering its preferential
enrichment at pericentric heterochromatin (Fig. 1), we asked
whether this increased concentration of MeCP2 could account
for the observed changes in heterochromatin clustering.
 
Ectopic expression of MeCP2-YFP 
induces clustering of pericentric 
heterochromatin independent of the 
histone H3K9 methylation pathway
 
To test whether MeCP2 plays a role in the aggregation of chro-
mocenters, we transfected mouse myoblasts with a MeCP2-
YFP fusion construct (Fig. 3, A and B) and performed a corre-
lation analysis comparing expression levels of MeCP2-YFP
with the number of chromocenters. 86 nuclei were first imaged
for MeCP2-YFP fluorescence by confocal microscopy, fol-
lowed by post-fixation and 3D-FISH with a major satellite-spe-
cific probe to visualize chromocenters. The correlation analysis
revealed a significant (P 
 
 
 
 0.01) negative correlation resulting
in a coefficient of 
 
 
 
0.52 (Fig. 3 D). Fig. 3 C shows two nu-
clei, one with low levels of MeCP2-YFP having many
chromocenters (top), whereas the other (bottom), with high
amounts of the fusion protein, shows only a few clusters. In ad-
dition to this reduction, also the variability in the number of
chromocenters decreased with increasing MeCP2-YFP expres-
sion, similar to the results in differentiating myoblasts (Fig. 2).
Control transfections using only YFP showed no effect on the
clustering of chromocenters (see Fig. 6 B). Furthermore, ex-
pression of high levels of MeCP2 fused to other tags (GFP or
DsRed variants) showed likewise clustering of chromocenters
(see Fig. 6 A). To investigate whether other proteins with a
similar nuclear localization as MeCP2 would be able to induce
heterochromatin clustering, we transfected mouse myoblasts
with constructs coding for fluorescently tagged versions of
CENPB and HP1
 
 
 
. Although CENPB has been shown to local-
ize at centromeric sites, in mouse chromosomes encompassing
a region made up by the so-called minor satellite repeat (Amor
et al., 2004), HP1
 
 
 
 is mainly found in pericentric heterochroma-
tin just as MeCP2, and represents one of the major constituents
Figure 2. Clustering of pericentric heterochromatin increases during
myogenesis. The histogram shows the number of chromocenters plotted
versus the percentage of nuclei within populations of terminally differenti-
ated myotubes (blue columns) and myoblasts (red columns). For each cell
type, a 3D reconstruction of the TO-PRO3 nuclear counterstaining (red) and
of pericentric heterochromatin labeled by a mouse major satellite-specific
probe (green) is shown.
Figure 3. MeCP2-YFP overexpression induces clustering of pericentric
heterochromatin, which is independent of the histone H3 methylation
pathway. Pmi28 myoblasts growing on etched coverslips were transiently
transfected with an MeCP2-YFP expression vector. Confocal image stacks
of 86 nuclei with different expression levels were recorded using constant
image acquisition parameters and their mean fluorescence intensity was
calculated. After post-fixation and FISH using a major satellite-specific
probe, pre-recorded nuclei were re-recorded to determine the number of
chromocenters. (A) Rat MeCP2-YFP fusion protein and its functional do-
mains (MBD, methyl CpG–binding domain; NLS, nuclear localization
signal; TRD, transcriptional repression domain; coRID, corepressor inter-
acting domain; numbers indicate amino acid positions). (B) Western blot
with an anti-GFP antibody verifying expression of the fusion protein in
transfected cells. (C) Images represent maximum intensity projections from
confocal stacks of Pmi28 myoblasts expressing different levels of MeCP2-
YFP. Bar, 5  m. (D) The graph illustrates the results of the correlation anal-
ysis. The linear equation for the regression line was calculated as y  
 0.04    19.41. Panels in E show MEF-D15 suv39h1/2 double-null
mouse fibroblasts transfected with MeCP2-YFP. Bar, 10  m. 
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of constitutive heterochromatin (for review see Singh and Geor-
gatos, 2003; Maison and Almouzni, 2004). In both cases we did
not find an increased clustering of chromocenters in cells ex-
pressing high levels of the fusion proteins (see Fig. 6 B and
Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200502062/DC1). These results clearly argue against a gen-
eral intrinsic clustering potential of centromeric or heterochro-
matin-associated proteins when expressed at high concentrations.
Next, we tested whether MeCP2-inducible clustering of
chromocenters would depend on the specific constitutive hetero-
chromatin modification of histone H3 (i.e., tri-methylation of
lysine 9) and its binding protein HP1. For that purpose, we trans-
fected mouse MEF-D15 fibroblasts (deficient for both histone
H3 methyltransferases Suv39h1 and Suv39h2; Peters et al.,
2001) with MeCP2-YFP. Both enzymes are responsible for tri-
methylation of histone H3 at lysine 9 at pericentric heterochro-
matin, which was shown to create a binding site for HP1
(Lachner et al., 2001). Transfected mutant cells exhibiting high
levels of MeCP2-YFP showed an increased clustering of chro-
mocenters despite lacking Suv39h1/2, histone H3K9 tri-methyl-
ation, and HP1 at pericentric sites (Fig. 3 E and Fig. S3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200502062/DC1),
showing that the aggregation mechanism is independent from
the HP1/H3K9 tri-methylation pathway.
Our experiments show that increased clustering of peri-
centric heterochromatin can be artificially induced by ectopic
expression of MeCP2 in the absence of differentiation. These
results indicate that the increased expression of endogenous
MeCP2 during terminal differentiation (Fig. 1) is sufficient
for inducing the observed aggregation of pericentric hetero-
chromatin.
 
Fusion of chromocenters occurs 
throughout interphase
 
Earlier reports have suggested a cell cycle–dependent redistri-
bution of centromeric regions within the nucleus (Manuelidis,
1985; Vourc’h et al., 1993). We therefore investigated when
during the cell cycle the fusion of chromocenters would take
place. For that purpose, we doubly transfected C2C12 myo-
blasts with MeCP2-YFP and DsRed-Ligase I (Fig. 4 A) as a
live-cell cell cycle progression marker (Easwaran et al., 2004,
2005). S-phase cells could be recognized simply by the subnu-
clear pattern of DsRed-Ligase I–labeled DNA replication foci
(Cardoso et al., 1997; Leonhardt et al., 2000), whereas mitotic
cells could be identified by chromosome condensation. G1
cells were identified by a previous mitosis or by a subsequent
S-phase and G2 cells by a previous S-phase or a successive mi-
tosis (Fig. 4 C). Of 14 nuclei analyzed, 9 showed fusions of
chromocenters (example in Fig. 4 B and Video 1, available at
http://www.jcb.org/cgi/content/full/jcb.200502062/DC1). A to-
tal of 30 fusions could be traced, with 15 occurring in G2, 10 in
G1, and 5 in S-phase (Fig. 4 D).
Our results thus show that MeCP2-YFP–induced chro-
mocenter clustering occurs through all interphase stages. The
number of chromocenters in daughter nuclei was similar to that
in the respective mother nuclei or higher, ruling out extensive
fusions by defective chromosome segregation during mitosis.
Besides fusion events we also observed extensive splitting of
heterochromatin clusters, occurring almost exclusively in G2
(Fig. S4 and Video 2, available at http://www.jcb.org/cgi/content/
full/jcb.200502062/DC1). Hence, disruption of pericentric het-
erochromatin is likely to be an important prerequisite to per-
form mitosis properly.
 
MeCP2-YFP–expressing cells exhibit 
enhanced chromocenter clustering 
during differentiation
 
Because MeCP2-YFP–transfected myoblasts were able to dif-
ferentiate and many myotubes contained nuclei with high levels
Figure 4. Fusion of chromocenters occurs throughout interphase. C2C12
myoblasts were double transfected with MeCP2-YFP and DsRed-Ligase I to
track cell cycle progression. Schematic diagrams of the fusion proteins are
depicted in A. (B) Maximum intensity projections generated from confocal
image stacks of four time points of an MeCP2-YFP–transfected myoblast
are shown (full time-lapse in Video 1, available at http://www.jcb.org/
cgi/content/full/jcb.200502062/DC1). MeCP2-YFP is shown in green,
phase-contrast images are in red. (C) As apparent from the DsRed-Ligase I
replication pattern, this cell was in late S-phase and moved into G2 after
3 h. In B, the last 180 min from the time series are shown. Three fusion
events are highlighted in different colors (yellow, white, and black). The
time points where the actual fusions take place are marked by an asterisk
and were analyzed in all three dimensions. Most observed fusions in-
cluded very close chromocenters, but as in the case highlighted in yellow
it could also affect chromocenters located  2  m apart. Bar (B and C),
5  m. The table in D summarizes the analysis from 14 time series. In 9 of
these cells chromocenter fusions occurred. 
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of the fusion protein, we conclude that overexpression of the
protein in no way disturbs differentiation. When we compared
the number of chromocenters in myotubes/myocytes showing a
high MeCP2-YFP expression with that of nontransfected con-
trols, we found significantly higher values in the control cells
(P 
 
 
 
 0.01 for myocytes and P 
 
 
 
 0.05 for myotubes; Fig. 5 A).
The mean number dropped from 14.5/11.1 in nontransfected
myocytes/myotubes to 9.6/9.5 in transfected and highly express-
ing cells (Fig. 5 B). This means that high level of expression of
MeCP2-YFP is not only compatible with the differentiation of
transfected myoblasts, but it actually enhances pericentric het-
erochromatin clustering during terminal differentiation.
 
The MBD of MeCP2 is sufficient and 
necessary to induce clustering of 
pericentric heterochromatin
 
At least three functional domains have been described for
MeCP2; a methyl CpG–binding domain (MBD), a transcrip-
tional repressor domain (TRD), and a corepressor interacting
domain (coRID) (Fig. 3 and Fig. 6). The MBD comprises 85
amino acids, located at the NH
 
2
 
-terminal end of the protein
spanning amino acid positions 78–162 (Nan et al., 1993).
This domain has been shown to be responsible for the interac-
tion with methylated cytosines, and a single methylated CpG
pair was shown to be sufficient for in vitro binding of the
MBD (Lewis et al., 1992; Nan et al., 1993). The TRD extends
from position 207 to 310 and was defined functionally by its
ability to convey transcriptional repression upon transiently
transfected reporter constructs (Nan et al., 1997). The NLS
lies within the TRD at positions 255–271 (Nan et al., 1996).
The coRID partially overlaps the TRD and extends NH
 
2
 
 ter-
minally until the MBD (aa 162). It was found to associate
with the corepressor complex constituents mSin3A and the
histone deacetylases HDAC1 and 2 (Nan et al., 1998), and
consequently suggested to convey transcriptional silencing
by recruiting chromatin-modifying complexes. Recently, a
fourth domain at the COOH terminus has been described that
apparently can interact with a domain found in splicing fac-
tors, though its function remains elusive (Buschdorf and
Stratling, 2004).
To test whether a specific domain of the MeCP2 protein
was responsible for the observed clustering of pericentric het-
erochromatin, we generated several truncated versions of
MeCP2 tagged with a fluorescent protein and scored the clus-
tering of chromocenters in cells expressing high concentra-
tions of the mutated proteins (Fig. 6 C). In particular, we
wanted to define whether the reported recruitment of histone
deacetylase containing corepressor complexes by the coRID
was needed for chromatin reorganization. All mutations hav-
ing COOH-terminal deletions but retaining the MBD (Fig. 6
Figure 5. Increased clustering during myogenic differentiation is enhanced
by high MeCP2-YFP expression. (A) The number of chromocenters in non-
transfected Pmi28 myocytes and myotubes (blue columns) was compared
with that in transfected Pmi28 myocytes and myotubes, which showed a
substantial overexpression of MeCP2-YFP (green columns). In transfected
cells, a clear shift toward a smaller number of clusters is evident. This ef-
fect is also visible if the mean number of chromocenters is compared (B).
Myocytes, which represent an intermediate differentiation state between
myoblasts and myotubes show also an intermediate number of chro-
mocenters in nontransfected cells (blue). Error bars indicate SEM.
Figure 6. The MBD is sufficient and necessary to induce clustering of peri-
centric heterochromatin I. The sketch shows the structure of various fusion
proteins that were expressed in mouse myoblasts in order to test for their
clustering potential.   and   indicate whether or not an increased aggre-
gation of pericentric heterochromatin could be observed in cells that
showed high levels of the respective fusion protein. (A) Induced clustering
by high MeCP2 expression could be observed irrespective of whether
YFP, GFP, or the nonrelated DsRed derivative mRFP was used as a fluores-
cent tag. (B) Neither YFP alone nor the DNA-binding domain of the centro-
meric protein CENPB nor the pericentric heterochromatin protein HP1 
appeared to induce clustering of pericentric regions (see also Fig. S2,
available at http://www.jcb.org/cgi/content/full/jcb.200502062/
DC1). (C) Truncated MeCP2 fusion proteins with increasing deletions of
the COOH terminus (a–c) including the transcriptional repressor domain
(TRD) and the corepressor interacting domain (coRID) were still able to in-
duce chromocenter clustering. Clustering was even observed for a dele-
tion mutant containing the MBD only (d). High level expression of an
MeCP2 fusion protein lacking the NH2 terminus including the MBD had no
clustering effect (e), arguing that the MBD is necessary and sufficient for
the induction of heterochromatin aggregation. 
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C, a–c) were able to induce clustering in mouse myoblasts, ar-
guing against the necessity of the TRD, the coRID, and the
most COOH-terminal portion of MeCP2 to induce aggrega-
tion of pericentric heterochromatin. In fact, a fusion construct
consisting of the MBD alone was sufficient to cause chro-
mocenter clustering in cells with high expression levels (Fig.
6 C, d; Fig. 7 A). In contrast, an NH
 
2
 
-terminal deletion mutant
lacking the MBD was not able to induce clustering, but in-
stead showed a markedly increased staining of nonpericentric
chromatin compared with the MBD-containing proteins, as
well as an increased localization in nucleoli (Fig. 7 B). How-
ever, this fusion protein retained a clear preference to localize
at pericentric sites (Fig. 7 C), arguing that the binding affinity
of MeCP2 for major satellite regions is not exclusively depen-
dent on the MBD.
Together, our deletion analysis clearly shows that the
MBD is necessary and sufficient to induce clustering of chro-
mocenters and is thus responsible for the observed clustering of
pericentric regions in cells expressing high amounts of MeCP2.
 
Clustering of pericentric 
heterochromatin occurs in muscle tissue 
of MeCP2-deficient mice
 
MeCP2 loss of function has been linked to the neurodevelop-
mental disorder Rett syndrome (Amir et al., 1999), in which
maturation of neuronal cells seems to be impaired, possibly
causing the severe neurological phenotype (for review see Kri-
aucionis and Bird, 2003). Concerning muscle development,
Rett syndrome patients as well as MeCP2 knock-out mice (Guy
et al., 2001; Shahbazian et al., 2002) show no severe defects
(Jellinger, 2003).
To directly test whether MeCP2 is required for cluster-
ing of pericentric heterochromatin during mouse develop-
ment, we compared chromatin topology in nuclei from muscle
fibers of MeCP2 knock-out mice with that of control mice.
Muscle fibers were stained with DAPI to highlight pericentric
heterochromatin and to investigate chromocenter clustering
(Fig. 8). Clustering of pericentric heterochromatin in skeletal
muscle tissue of MeCP2-deficient mice was comparable to
that in wild-type mice (Fig. 8) and in vitro differentiated myo-
tubes (Fig. 2). These results clearly indicate that clusters of
chromocenters can form in the absence of MeCP2, and we hy-
pothesized that another member of the MBD protein family
might be capable to reorganize chromocenters in a similar
fashion as MeCP2.
 
MBD2, but not MBD3, induces 
clustering of pericentric heterochromatin 
and, like MeCP2, its level increases 
during myogenic differentiation
 
MeCP2 belongs to a protein family that comprises at least five
members, all of which share a functional MBD, besides
MBD3, that is consequently incapable to specifically bind to
methylated DNA (Hendrich and Bird, 1998). MBD2, like
MeCP2, has been shown in transient transfection assays to lo-
calize preferentially at pericentric heterochromatin in a DNA
methylation–dependent manner (Hendrich and Bird, 1998).
Therefore, we tested if MBD2 could also induce chromocenter
aggregation if expressed at high levels. Cells with high levels
of an ectopically expressed GFP-MBD2 showed a signifi-
cantly smaller number of chromocenters than nontransfected
control cells (Fig. 9, A and B). Moreover, expression of en-
dogenous MBD2 protein showed a stark increase during myo-
genic differentiation (Fig. 9 C), paralleling that of MeCP2
(Fig. 1 D). The observation that GFP-MBD2 can induce chro-
mocenter clustering is in good agreement with the findings of
our deletion analysis, showing that the MBD is sufficient to in-
duce chromocenter clustering (Fig. 6 and Fig. 7). Indeed, we
found also indications for an increased chromocenter cluster-
ing when we overexpressed GFP-tagged MBD1 and MBD4
(unpublished data), which also contain a functional MBD, and
as assessed in transfection assays localize preferentially at
pericentric sites (Hendrich and Bird, 1998). We also trans-
fected mouse myoblasts with GFP-MBD3, which has been
Figure 7. The MBD is sufficient and necessary to induce clustering of
pericentric heterochromatin II. Pmi28 mouse myoblasts were transfected
with several MeCP2 deletion mutants tagged with YFP or GFP. In the ex-
amples shown, cells were transfected with a vector containing only the
MBD of MeCP2 fused to YFP (A), or with an MeCP2-GFP fusion lacking
the first 162 amino acids including the MBD (B and C). A and B represent
maximum intensity projections of confocal image stacks, except for the
phase-contrast image, which is a mid-section. (C) Two mid-confocal sec-
tions. Bars, 10  m. (A) Note that the cell expressing high levels of MBD-
YFP exhibits a more pronounced clustering of chromocenters compared
with nonexpressing cells, as revealed by TO-PRO 3 staining. (B) MeCP2-
GFP lacking the NH2 terminus (MeCP2(aa 163–492)-GFP) is highly con-
centrated in nucleoli (n) and did not induce chromocenter clustering. (C)
Though lacking the MBD, the fusion protein still showed a preference for
pericentric regions, although the contrast between nucleoplasmic and
chromocenter staining is markedly reduced, compared with A. This pref-
erence for pericentric heterochromatin is also evident from the line scan
plot. The blue line represents the track of the line scan; “1” and “2” mark
chromocenter positions. 
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shown to distribute diffusely in the nucleus with no preference
for major satellite regions, if expressed at moderate levels
(Hendrich and Bird, 1998). As expected, we found no indica-
tion for an increased chromocenter clustering in cells express-
ing high amounts of GFP-MBD3 (Fig. 9 D). Instead, we found
an underrepresentation of GFP-MBD3 at pericentric sites (Fig.
9 E). A similar diffuse nucleoplasmic staining of MBD3 with a
decreased concentration at major satellite regions was ob-
served for the endogenous protein visualized by immunofluo-
rescence in mouse myoblasts (unpublished data). Furthermore,
MBD3 protein level did not show a significant increase during
differentiation (Fig. 9 C).
Given the clustering potential of GFP-MBD2 and its in-
creased expression level in differentiated myotubes, we conclude
that MBD2 can substitute for MeCP2 in MeCP2 knock-out mice
(Fig. 8), indicating a functional redundancy.
 
Discussion
 
Our data provide evidence that aggregation of pericentric hetero-
chromatin is a general feature of terminally differentiating myo-
tubes, and that this major reorganization of nuclear topology can
be induced by MeCP2 and MBD2. Furthermore, this rearrange-
ment of heterochromatin is independent of the histone H3 tri-
methylation pathway and can occur throughout interphase.
A possible mechanism to explain how increasing levels
of MeCP2 and MBD2 may contribute to aggregation of hetero-
chromatin could involve oligomerization of these proteins
bound to chromatin. These factors are not likely to be involved
in movements of chromocenters or other chromatin regions,
per se, but rather act as a sort of “glue” stabilizing random en-
counters of chromocenters within the nucleus. This is sup-
ported by a recent report (Georgel et al., 2003) showing that
MeCP2 has the ability to interconnect nucleosomal arrays in
vitro, creating oligomers consisting of several units. The au-
thors have proposed DNA–MeCP2–MeCP2–DNA or DNA–
MeCP2–DNA bridges to be responsible for the observed
chromatin condensation activity. Such a mechanism could ac-
count for the clustering of pericentric heterochromatin during
terminal differentiation simply by an increased interconnection
due to elevated MeCP2 levels bound to methylated DNA. In
this respect it should be noted that recombinant MeCP2 treated
with the cross-linkers glutaraldehyde or EGS did not support a
self-association of MeCP2 monomers (Klose and Bird, 2004).
Figure 8. Clustering of pericentric heterochromatin occurs in
muscle tissue of wild-type mice as well as in MeCP2 knock-out
mice. Whole mouse myofibers from wild-type mice and MeCP2
null mice were fixed in formaldehyde and stained with DAPI to
visualize myotube nuclei and chromocenters. Similar to in vitro–
generated myotubes, a high fraction of nuclei showed an in-
creased clustering of pericentric heterochromatin, i.e., chro-
mocenters were large in size and few in number. In the widefield
epifluorescent images shown, DAPI staining is in white and
phase-contrast in red. Chromocenters are highlighted as in-
tensely stained regions. Muscle fibers showed the characteristic
striation by phase-contrast imaging, representing the sarcomeric
organization. Bars, 20  m.
Figure 9. MBD2 increases during myogenic
differentiation and, in contrast to MBD3, binds
to and induces clustering of pericentric het-
erochromatin in a dose-dependent manner.
Mouse myoblasts were transfected with GFP-
MBD2 or GFP-MBD3 fusion constructs to test
whether high expression levels of the fusion
proteins would effect clustering of pericentric
regions. In A and D, projection of confocal
image stacks are shown. Bars, 20  m. Note
that the cell expressing high levels of GFP-
MBD2 shows a remarkable increase in clus-
tering of chromocenters as highlighted by TO-
PRO counterstaining, whereas the nucleus
with a high concentration of GFP-MBD3
shows an organization of pericentric hetero-
chromatin, comparable to nonexpressing
cells. Statistical analysis revealed that the
number of chromocenters in cells expressing
high levels of GFP-MBD2 is significantly re-
duced. The corresponding histogram in B illus-
trates the distinct distribution of chromocenter
number of such cells (green) compared with
nontransfected controls (blue). (C) Immunoblotting comparing endogenous levels of MBD2 and MBD3 in myoblasts versus myotubes. Histone concentra-
tions were used as loading controls for nuclear proteins. (E) Mid-confocal section of the myoblast nucleus shown in D expressing high levels of GFP-
MBD3. Bar, 10  m. The blue line highlights the path of a line scan crossing four chromocenters (1–4, stained by TO-PRO3). The corresponding fluo-
rescence intensity profile along the path shown in the plot demonstrates a decreased concentration of GFP-MBD3 in pericentric heterochromatin foci
(fluorescent peaks at 1–4) and in the nucleolus. 
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However, it remains to be tested whether mouse MeCP2 is ca-
pable of forming multimers under other conditions, i.e., in a
nuclear environment and bound to methylated satellite repeats.
Because MeCP2 and MBD2 are highly basic proteins
(with pI 
 
 
 
10, similar to histones), they could act in a similar
way as proposed for linker histones or inorganic bivalent cat-
ions (for review see Horn and Peterson, 2002) by neutralizing
negative charges on the DNA, and thereby enabling or en-
hancing interactions between major satellite DNA located on
separate chromocenters. Increased methylation of CpGs in
pericentric regions (Fig. 1, C and E), creating a higher num-
ber of binding sites for MeCP2 and MBD2, would increase
the probability of these proteins to bind, thereby augmenting
their aggregation effect. However, the moderate degree of
DNA methylation in the cell types analyzed suggests that ex-
tensive DNA methylation is not necessary for pericentric het-
erochromatin clustering. This is in agreement with a recent
report showing that the compaction of oligonucleosomes by
MeCP2 in vitro is not dependent on DNA methylation (Geor-
gel et al., 2003).
Alternatively or in addition, a differentiation-dependent
increase of MeCP2 could lead to a raise in the local concentra-
tion of histone deacetylases and/or of other chromatin-remod-
eling factors, which could bring about the observed aggregation
effect. However, our results showing that the MBD domain
alone, in the absence of the coRID, is sufficient for chro-
mocenter reorganization (Fig. 6 and Fig. 7), argue against a
role of the recruitment of deacetylase-containing complexes
in the large-scale heterochromatin reorganization during dif-
ferentiation. Also, the recently described recruitment of a his-
tone H3K9 methylation activity by MeCP2 (Fuks et al., 2003)
is unlikely to play a major role because mouse Suv39h dou-
ble-null fibroblasts still showed increased clustering of peri-
centric heterochromatin upon MeCP2 overexpression, just as
wild-type fibroblasts (unpublished data) or myoblasts did
(Fig. 3 E). Altogether, our data favor a more direct and struc-
tural role of methyl CpG–binding proteins in chromatin reor-
ganization rather than an indirect role through recruiting
corepressor complexes.
Another aspect contributing to the clustering of pericen-
tric heterochromatin in terminally differentiated, post-mitotic
cells could be an intrinsic ability to aggregate during inter-
phase, which in proliferating cells would be counteracted at
each cell cycle by the dissociation of chromocenters as chro-
mosomes condense and are separated during mitosis. With
live-cell microscopy we could indeed follow such extensive
dissociations of chromocenters in G2 nuclei before mitosis
(Fig. S4 and Video 2). In post-mitotic, terminally differentiated
cells, where chromosomes are no longer subjected to mitotic
events, this “default” aggregation affinity would not be coun-
teracted and might be further enhanced by MeCP2 and MBD2,
finally leading to very large clusters.
A possible function of this nuclear reorganization of peri-
centric heterochromatin could be the establishment and/or sta-
ble maintenance of a specific transcriptional program in dif-
ferentiated cells. The fact that heterochromatin, especially
pericentric heterochromatin, conveys transcriptional silencing
in many different settings, starting from position effect variega-
tion (for review see Schotta et al., 2003) over transgene silenc-
ing (Francastel et al., 1999) to endogenous gene silencing (for
review see Fisher and Merkenschlager, 2002), would support
this hypothesis. It is conceivable that the silencing effects de-
pend on a local threshold concentration of factors that are
bound to or attracted by pericentric heterochromatin or some of
its constituents. Forming bigger clusters would thus bring
about an increase of such a critical concentration leading ulti-
mately to the formation of effective silencing domains. Our re-
sults showing that MeCP2, which is known to act as a tran-
scriptional repressor, plays an important role in inducing
aggregation of heterochromatin clusters also favors this idea.
Recently, it has been proposed that MeCP2 might be involved
in the reduction of transcriptional noise (Hendrich and
Tweedie, 2003). This function could be enhanced by a nuclear
clustering that provides stringent control of leaky transcription
via the creation of repressive subnuclear compartments. More-
over, our results showing that chromocenter clustering is main-
tained in MeCP2-deficient mice (Fig. 8) further strengthen the
hypothesis that this large-scale topological chromatin reorgani-
zation might be of functional relevance, as it involves redun-
dant pathways.
The finding that MeCP2 deficiency does not have a pro-
nounced effect on gene expression pattern (Tudor et al., 2002)
speaks in favor of MeCP2 being involved in stabilizing tran-
scriptional silencing in terminally differentiated cells, rather
than in regulating gene expression during differentiation. A re-
cent report correlating the level of MeCP2 protein during central
nervous system development in the mouse with the maturation
of neurons further suggests that MeCP2 is involved in mainte-
nance of the differentiated state, rather than in cell fate decisions
(Kishi and Macklis, 2004). Alternatively, functional redun-
dancy between MeCP2 and other methyl CpG–binding pro-
teins such as MBD1 or MBD2, which have a similar pericentric
distribution, could also explain the merely subtle changes in
gene expression patterns observed in MeCP2-deficient mice
(Tudor et al., 2002). Such a functional redundancy between
MBD proteins is supported by our findings that MBD2 can
likewise induce heterochromatin clustering and is expressed in
a differentiation-dependent manner (Fig. 9). To which extent
other MBDs can actually back up MeCP2 function has yet to
be determined. Double or triple knockouts including MeCP2,
MBD2, and MBD1 are required to further elucidate functional
redundancies within the MBD protein family.
Both aspects of MeCP2 function (i.e., stabilization of
transcriptional patterns and functional redundancy with other
MBDs) would also explain why Rett syndrome patients as well
as MeCP2 knock-out mice are viable and form differentiated
tissues (for review see Kriaucionis and Bird, 2003), indicating
that MeCP2 is not, per se, essential for cellular differentiation.
Our results clearly show that MeCP2 and MBD2 pro-
tein levels dramatically increase during differentiation and
that either of them is sufficient to induce a large-scale chro-
matin reorganization during terminal differentiation, and thus
represent a molecular link between nuclear genome topology
and cellular differentiation. 
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Materials and methods
 
Plasmid constructs
 
The complete rat MeCP2 ORF as well as the DNA-binding domain of hu-
man CENPB (aa 1–169; Shelby et al., 1996) were fused in frame at the
NH
 
2
 
 terminus of the enhanced YFP (pEYFP-N1 vector; CLONTECH Labora-
tories, Inc.). The YFP-containing part from MeCP2-YFP fusion was cut out
and replaced by either enhanced GFP (isolated from pEGFP-N1 vector;
CLONTECH Laboratories, Inc.) or mRFP1 (Campbell et al., 2002) to con-
struct MeCP2-GFP and MeCP2-mRFP1, respectively. MeCP2 deletion mu-
tants were generated from the above plasmids using conveniently located
restriction enzyme sites or by PCR amplification using primers including
compatible restriction sites (primer sequences are available upon request).
The complete human DNA ligase I ORF was fused in frame at the COOH
terminus of the DsRed1 gene (pDsRed1-C1; CLONTECH Laboratories, Inc.)
(Easwaran et al., 2004, 2005). The GFP-HP1
 
 
 
 (human HP1
 
 
 
; Cheutin et
al., 2003); GFP-MBD2 (human MBD2a; Tatematsu et al., 2000); MBD1-
GFP, MBD4-GFP, and GFP-MBD3 (mouse cDNAs for MBD1, MBD4, and
MBD3; Hendrich and Bird, 1998); and FLAG-HP1
 
 
 
 (FLAG epitope–tagged
mouse HP1
 
 
 
; Nielsen et al., 2001) were as described. Correct expression
of all fusions in mammalian cells was checked by Western blot analysis as
described before (Cardoso et al., 1997; Easwaran et al., 2005).
 
Mouse tissue, cell culture, and transfection
 
Mouse muscle fibers from 50-d-old male MeCP2
 
 
 
/y (Guy et al., 2001)
and from 12-wk-old male C57BL/6J used as controls were dissected from
the hind limb and immediately frozen.
C2C12 mouse myoblasts and Pmi28 primary mouse myoblasts
were cultured and differentiated as described previously (Cardoso et al.,
1997; Kaufmann et al., 1999). The suv39h1/2 double-null and wild-type
mouse fibroblasts (MEF-D15 and MEF-W9, respectively) were cultured as
described before (Peters et al., 2001).
Pmi28 cells were transfected with PolyFect reagent (QIAGEN). For
in vivo analysis, cells were transfected by the Ca
 
3
 
(PO
 
4
 
)
 
2
 
 coprecipitation
method as described previously (Cardoso et al., 1997).
To relocate MeCP2-YFP–expressing cells after post-fixation and
FISH procedures, cells were cultivated on coverslips that featured 500
photoetched alphanumerical squares (Bellco). Myocytes were identified as
postmitotic single nucleated cells in differentiated myotube cultures. To ex-
clude cell cycle–dependent influences we included only S-phase cells for
the evaluation of cycling myoblasts identified by pulse-labeling with BrdU
(10 
 
 
 
M) 30 min before fixation. To determine post-mitotic cells, i.e., G0
cells, fixation was preceded by a 24-h BrdU (10 
 
 
 
M) incubation period.
Details on BrdU detection can be found in Solovei et al. (2001).
 
Western blotting
 
To compare the level of endogenous MeCP2, MBD2, and MBD3 protein
in myoblasts versus myotubes, it was important to normalize for equivalent
number of nuclei because myoblasts and myotubes have a very different
cytoplasm/nucleus ratio and the methyl CpG–binding proteins are exclu-
sively nuclear. For that purpose, DNA amounts from the different samples
were measured using the Hoechst 33258 dye on a fluorimeter, and the ar-
bitrary Hoechst fluorescence units from different cell suspension volumes
were then compared to calculate equal nuclei amounts of cell suspension.
Equivalent DNA-containing cell suspension aliquots were directly boiled in
Laemmli loading buffer so that also insoluble proteins were solubilized
and loaded onto the SDS-PAGE gels. This step was also relevant because
methyl CpG–binding proteins are mostly bound to chromatin containing
methylated DNA and therefore not efficiently extracted from the cells.
MeCP2 was detected with a rabbit pAb (Abcam); MBD2 and MBD3 with
a goat pAb (Santa Cruz Biotechnology, Inc.). Antibody specificity was
tested by probing extracts of cells overexpressing tagged versions of all
other family members with each individual antibody. Nuclear protein
amounts were controlled by probing with an anti-histone mouse mAb
(Roche clone H11-4).
 
FISH and immunofluorescence
 
FISH with a mouse major satellite-specific probe was performed as de-
scribed in Weierich et al. (2003). In brief, cells were fixed with 4% PFA in
1
 
  
 
PBS for myoblasts and in 0.75
 
  
 
PBS for myotubes. Cells were perme-
abilized with 0.5% Triton X-100/1
 
  
 
PBS followed by incubation in 20%
glycerol and a repeated freezing/thawing step in liquid nitrogen. Addi-
tional pretreatments included incubation in 0.1 N HCl and for myoblasts/
myotubes a pepsinization step.
The probe was generated by PCR using 5
 
 
 
-GCGAGAAAACT-
GAAAATCAC-3
 
 
 
 and 5
 
 
 
-TCAAGTCGTCAAGTGGATG-3
 
 
 
 as primers and
mouse genomic DNA as template and labeled by nick translation using
TAMRA-dUTP.
For immunofluorescence, cells were fixed as described for FISH
until the Triton X-100 step. Mouse muscle fibers were fixed and perme-
abilized as cultured cells, but incubating 15 min for fixation and 40 min
for permeabilization.
Detection of methylated DNA was performed as described previ-
ously (Habib et al., 1999). The following primary antibodies were used:
rabbit anti-MeCP2 (Upstate Biotechnology) 1:25; mouse anti-5mC (Euro-
gentec) 1:100; goat anti-MBD3 (Santa Cruz Biotechnology, Inc.) 1:25; and
mouse anti-FLAG M2 (Kodak) 1:2,000. As secondary antibodies we used
goat anti–rabbit IgG-FITC (Sigma-Aldrich), goat anti–mouse IgG-Alexa 488
(Molecular Probes, Inc.), and donkey anti–goat IgG-Cy3 (Rockland).
Nuclear counterstaining was done using DAPI, Hoechst 33258,
or TO-PRO 3. Samples were mounted in Vectashield antifade (Vector
Laboratories).
 
Southern blot
 
Genomic DNA from undifferentiated Pmi28 myoblasts and from differenti-
ated cultures (6 d after application of differentiation medium) was isolated
by spooling according to Sambrook and Russel (2001). Equal amounts of
genomic DNA (5 
 
 
 
g) were digested overnight with the methylation-sensitive
restriction enzyme HpyCH4 IV (5
 
 
 
-ACGT-3
 
 
 
) (New England Biolabs, Inc.),
analyzed by 1.2% agarose gel electrophoresis, and blotted onto Zeta-Probe
membrane (Bio-Rad Laboratories). A major satellite-specific probe was gen-
erated by PCR as described for FISH, whereas a PCR fragment correspond-
ing to a repeat monomer was used, which was extracted by gel elution and
labeled radioactively by random priming method (Prime-It II; Stratagene).
After overnight hybridization, the membrane was washed and exposed to a
phosphor screen. Signals were detected on a phosphorimager.
 
Microscopy
 
Epifluorescence microscopy was performed at RT using an Axiophot 2
with 63
 
 
 
/1.4 oil and 100
 
 
 
/1.3 oil lenses (Carl Zeiss MicroImaging,
Inc.), equipped with a Coolview CCD camera system (Photo Science Ltd.).
Images were acquired with Cytovision software (Applied Imaging). Confo-
cal image stacks were collected with an LSM410 and LSM510 micro-
scope (Carl Zeiss MicroImaging, Inc.), equipped with 63
 
 
 
/1.4 oil and
63
 
 
 
/1.4 oil Ph3 lenses, respectively, at ambient temperature. For living-
cell microscopy we used an FCS2 heated live cell observation chamber
(Bioptechs) in combination with the Zeiss LSM510 microscope. The cham-
ber was kept at a constant temperature of 37
 
 
 
C. The lateral resolution was
between 0.05 and 0.1 
 
 
 
m. The axial resolution was between 0.2 and
0.5 
 
 
 
m in fixed cells and 0.75 
 
 
 
m in living cells. The temporal resolution
of time series was 1 h.
 
Image analysis and evaluations
 
Endogenous MeCP2 levels and methylation of cytosines visualized by im-
munofluorescence were evaluated by wide-field epifluorescence micros-
copy. The fraction of cells showing pericentromeric staining was deter-
mined by visual inspection.
Chromocenters were counted from confocal stacks using Image
Browser software (Carl Zeiss MicroImaging, Inc.) by scanning the xy
plane plus additionally inspecting z planes to discriminate between sig-
nals on top of each other.
Quantification of MeCP2-YFP fluorescence for the correlation analy-
sis was done by determining the intranuclear mean fluorescence intensity
of YFP using Image J software. As a first step, a threshold-defined counter-
stain-derived binary stack was created that defined the nuclear volume.
This was used to set the signal intensity of all extranuclear voxels within
the MeCP2-YFP channel to zero. All the remaining voxels were defined as
intranuclear and their mean voxel intensity calculated.
Correlation analysis was performed using SPSS 11.5 software as-
suming a linear correlation. Differences between chromocenter numbers in
different cell types were tested for statistical significance by comparing cu-
mulative frequencies within individual cell populations using a two-sample
Kolmogorov-Smirnov test.
Line scan analysis was performed on confocal mid-section images
using LSM 5 Image Examiner software (Carl Zeiss MicroImaging, Inc.).
 
Online supplemental material
 
Video 1 and Video 2 show dynamic behavior of pericentric heterochro-
matin in C2C12 mouse myoblasts visualized in vivo. Fig. S1 depicts chro-
mocenter number during myogenic differentiation. Fig. S2 shows that high
level expression of GFP-HP1
 
 
 
 does not induce clustering of pericentric het-
erochromatin. Fig. S3 shows that HP1-
 
 
 
 does not localize at pericentricJCB • VOLUME 169 • NUMBER 5 • 2005 742
heterochromatin in Suv39h double-null fibroblasts. Fig. S4 depicts splitting
of chromocenters in a G2 cell. Online supplemental material available at
http://www.jcb.org/cgi/content/full/jcb.200502062/DC1.
Pmi28 myoblasts were provided by A. Starzinski-Powitz (Johann Wolfgang
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